These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 28860142)
21. Surfactant replacement and open lung concept--comparison of two treatment strategies in an experimental model of neonatal ARDS. Hilgendorff A; Aslan E; Schaible T; Gortner L; Baehner T; Ebsen M; Kreuder J; Ruppert C; Guenther A; Reiss I BMC Pulm Med; 2008 Jul; 8():10. PubMed ID: 18625067 [TBL] [Abstract][Full Text] [Related]
22. Acute and sustained effects of lucinactant versus poractant-alpha on pulmonary gas exchange and mechanics in premature lambs with respiratory distress syndrome. Gastiasoro-Cuesta E; Alvarez-Diaz FJ; Rey-Santano C; Arnaiz-Renedo A; Loureiro-Gonzalez B; Valls-i-Soler A Pediatrics; 2006 Feb; 117(2):295-303. PubMed ID: 16452346 [TBL] [Abstract][Full Text] [Related]
23. In vitro characterization and in vivo comparison of the pulmonary outcomes of Poractant alfa and Calsurf in ventilated preterm rabbits. Guo X; Luo S; Amidani D; Rivetti C; Pieraccini G; Pioselli B; Catinella S; Murgia X; Salomone F; Xu Y; Dong Y; Sun B PLoS One; 2020; 15(3):e0230229. PubMed ID: 32168331 [TBL] [Abstract][Full Text] [Related]
24. Prolonged ventilation of the premature newborn rabbit after treatment with natural or apoprotein-based artificial surfactant. Robertson B; Curstedt T; Grossmann G; Kobayashi T; Kokubo M; Suzuki Y Eur J Pediatr; 1988 Feb; 147(2):168-73. PubMed ID: 3366134 [TBL] [Abstract][Full Text] [Related]
25. Impact of synthetic surfactant CHF5633 with SP-B and SP-C analogues on lung function and inflammation in rabbit model of acute respiratory distress syndrome. Mikolka P; Curstedt T; Feinstein R; Larsson A; Grendar M; Rising A; Johansson J Physiol Rep; 2021 Jan; 9(1):e14700. PubMed ID: 33403805 [TBL] [Abstract][Full Text] [Related]
26. Surfactant lavage decreases systemic interleukin-1 beta production in meconium aspiration syndrome. Wang PW; Jeng MJ; Wang LS; Fang LJ; Soong WJ Pediatr Int; 2010 Jun; 52(3):432-7. PubMed ID: 19919635 [TBL] [Abstract][Full Text] [Related]
27. MiR-24 inhibits inflammatory responses in LPS-induced acute lung injury of neonatal rats through targeting NLRP3. Lin Y; Yang Y Pathol Res Pract; 2019 Apr; 215(4):683-688. PubMed ID: 30600184 [TBL] [Abstract][Full Text] [Related]
28. In vivo effect of surfactant on inflammatory cytokines during endotoxin-induced lung injury in rodents. Mittal N; Sanyal SN J Immunotoxicol; 2011; 8(4):274-83. PubMed ID: 21767135 [TBL] [Abstract][Full Text] [Related]
29. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation. Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158 [TBL] [Abstract][Full Text] [Related]
30. Spontaneous breathing or mechanical ventilation alters lung compliance and tissue association of exogenous surfactant in preterm newborn rabbits. Bohlin K; Bouhafs RK; Jarstrand C; Curstedt T; Blennow M; Robertson B Pediatr Res; 2005 May; 57(5 Pt 1):624-30. PubMed ID: 15718361 [TBL] [Abstract][Full Text] [Related]
31. Recombinant human Clara cell secretory protein treatment increases lung mRNA expression of surfactant proteins and vascular endothelial growth factor in a premature lamb model of respiratory distress syndrome. Wolfson MR; Funanage VL; Kirwin SM; Pilon AL; Shashikant BN; Miller TL; Shaffer TH Am J Perinatol; 2008 Nov; 25(10):637-45. PubMed ID: 18841530 [TBL] [Abstract][Full Text] [Related]
32. Open lung ventilation preserves the response to delayed surfactant treatment in surfactant-deficient newborn piglets. van Veenendaal MB; van Kaam AH; Haitsma JJ; Lutter R; Lachmann B Crit Care Med; 2006 Nov; 34(11):2827-34. PubMed ID: 17006360 [TBL] [Abstract][Full Text] [Related]
33. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R; Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381 [TBL] [Abstract][Full Text] [Related]
34. Saikosaponin a Ameliorates LPS-Induced Acute Lung Injury in Mice. Du ZA; Sun MN; Hu ZS Inflammation; 2018 Feb; 41(1):193-198. PubMed ID: 28986747 [TBL] [Abstract][Full Text] [Related]
35. Reducing atelectasis attenuates bacterial growth and translocation in experimental pneumonia. van Kaam AH; Lachmann RA; Herting E; De Jaegere A; van Iwaarden F; Noorduyn LA; Kok JH; Haitsma JJ; Lachmann B Am J Respir Crit Care Med; 2004 May; 169(9):1046-53. PubMed ID: 14977624 [TBL] [Abstract][Full Text] [Related]
36. New surfactant with SP-B and C analogs gives survival benefit after inactivation in preterm lambs. Seehase M; Collins JJ; Kuypers E; Jellema RK; Ophelders DR; Ospina OL; Perez-Gil J; Bianco F; Garzia R; Razzetti R; Kramer BW PLoS One; 2012; 7(10):e47631. PubMed ID: 23091635 [TBL] [Abstract][Full Text] [Related]
37. Synthetic lung surfactants containing SP-B and SP-C peptides plus novel phospholipase-resistant lipids or glycerophospholipids. Notter RH; Gupta R; Schwan AL; Wang Z; Shkoor MG; Walther FJ PeerJ; 2016; 4():e2635. PubMed ID: 27812430 [TBL] [Abstract][Full Text] [Related]
38. Chemically modified tetracycline prevents the development of septic shock and acute respiratory distress syndrome in a clinically applicable porcine model. Steinberg J; Halter J; Schiller H; Gatto L; Carney D; Lee HM; Golub L; Nieman G Shock; 2005 Oct; 24(4):348-56. PubMed ID: 16205320 [TBL] [Abstract][Full Text] [Related]
39. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages. Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403 [TBL] [Abstract][Full Text] [Related]
40. Artificial surfactant in preterm rabbits with and without respiratory distress syndrome: difference of in vitro and in vivo activities. Obladen M; Kampmann W; Zimmermann I; Lachmann B Eur J Pediatr; 1985 Jul; 144(2):195-9. PubMed ID: 3850023 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]